Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

030D6DA7FFEE16BA872588400003E0CF Hearing Summary





HB22-1326 -


06:42:25 PM  

The committee was called to order. A quorum was present. Representative Garnett, prime sponsor and chair of the conference committee, explained the differences between the two houses on House Bill 22-1326. The bill concerns measures to address synthetic opiates, and, in connection therewith, changing the criminal penalties associated with synthetic opiates; using a substance abuse assessment to direct appropriate treatment at sentencing; providing opiate antagonists in the community; providing synthetic opiate detection tests in the community; creating immunity for furnishing synthetic opiate detection tests; providing treatment for persons in the criminal justice system; developing a fentanyl prevention and education campaign; providing funding for substance use and harm reduction; evaluating the substance use and harm reduction needs across the state; and equiring a post-enactment review of the implementation of the act. Various members of the conference committee weighed in on the forthcoming conference committee report, and the process of crafting the bill as it went forward.

06:45:30 PM  
The conference committee
discussed the first report of the first conference committee on HB 22-1326
(Attachment A).
06:52:32 PM  
Discussion continued regarding the effect of the first report of the first conference committee on HB 22-1326.


06:54:57 PM
Motion Adopt the first report of the first conference committee on House Bill 22-1326, CLHB 1326.005.
Moved Pettersen
Seconded Tipper
Cooke Yes
Hansen Yes
Lynch Yes
Tipper Yes
Pettersen Yes
Garnett Yes
Final YES: 6   NO: 0   EXC: 0   ABS:  0   FINAL ACTION:  PASS






Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses.  Details